The top analyst upgrades, downgrades and initiations seen on Monday morning include Chesapeake Energy, Motorola Solutions, Pfizer, Spirit Air, Symantec, Under Armour and US Foods.
June 17, 2016: Markets opened lower again Friday after a somewhat disappointing report on U.S. housing starts. St. Louis Fed president James Bullard suggested that interest rate hikes may be far less…
June 15, 2016: Markets opened higher Wednesday on hopes that the the FOMC meeting would leave interest rates unchanged, the outcome most people expected and the actual outcome as it turned out.…
Pfizer made waves early on Tuesday after it announced a new licensing deal with Shire for an investigational biologic.
Chris Lange The May 31 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest was mixed.
June 8, 2016: Markets opened higher for a third straight day Wednesday boosted by rising crude oil prices and a falling dollar. An premarket jump in shares of LendingClub helped out until…
Merrill Lynch is one of the major firms that will be in attendance at the American Society of Clinical Oncology (ASCO) annual meeting, and it has issued a report on what it…
The American Society of Clinical Oncology (ASCO) is gearing up for its annual meeting. At this meeting, cancer drug developers will share the results from their most recent drug trials.
Despite the ongoing political candidate chirping, all of these quality big pharmaceutical stocks have been around, and they will continue to stay around.
The May 13 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest was mixed.
However, one medical supply company stood out, as short sellers piled on Baxter International in the first two weeks of the month.
ASCO has just released the abstracts for its exhibitors ahead of the conference. For investors and analysts, sometimes winners or losers from the meeting can be divined ahead of time by these…
Pfizer has announced that it has reached a definitive agreement to acquire Anacor Pharmaceuticals in a deal valued at more than $5 billion.
The king of biotech and pharma events is about to take place. The 2016 annual meeting of the American Society of Clinical Oncology (ASCO) is set to run from June 3 to…
The short interest data have been released for the April 29 settlement date, and for most of the selected pharmaceutical stocks short interest decreased.
